For the complete report, get in touch with us at : info@netscribes.com The stem cell research in India is in its nascent stage and is gradually on a growth path of acceptance by people. The market is still in a phase of conducting research to establish itself as one of the best therapies for the widely prevalent incurable lifestyle diseases. Awareness campaigns and doctors are playing a key role educating people and especially would-be parents about the benefits associated with preserving stem cells. The report begins with the introduction section which offers a brief insight of the concept of stem cell therapy and banking, the conventional sources of stem cells and the current and future therapeutic solutions for the most risky diseases. It then moves to the market overview section which provides an insight of the Indian stem cell therapy market, with highlight on the market size and growth. It also covers the market size and growth prospect of the stem cell banking market in India. In addition to these, the report gives a snapshot of the current and expected stem cell banking customers. An analysis of the drivers explains the factors for growth of the industry that include favourable regulatory environment, high patient population, stem cell application in drug development, rising consumer awareness, a rise in medical tourism and an increase in research and development expenditure to ensure stem cell therapy as a viable treatment for the numerous diseases. The key challenges include high cost of therapy, capital intensive market and high development costs of stem cell resulting in slow progress of the market. The next section of the report provides the progressive stages that the stem cell research is undergoing and the respective business prospect for each of the stages of business involved. The report then covers the key trends that are being observed in the stem cell research. Collaborations and partnerships are becoming a trend that is helping in healthy progress of the business, investments are pouring in from government, international organizations and pharmaceutical companies, serious efforts are being undertaken to raise awareness standards regarding stem cell therapy and the move is being popularized by stem cell banks by providing easy financing opportunities for banking stem cells. Significant developments have emerged wherein new sources of stem cells have been identified – dental stem cells and menstrual blood stem cells which have been discussed along with its benefits in comparison to cord blood stem cells. The competition section gives overview of stem cell banks and stem cell research organizations in the country. The report highlights the features of the major players operating in the market in detail. It includes elaborate profile of the major players in the market along with their financial analysis. Porters Five Forces Analysis has been incorporated

1. Insert Cover Image using Slide Master View
Do not distort
Stem Cell Research – India
Stem Cell Research India
July 2012

2. Executive Summary
• The Stem Cell Therapy market in India was valued at INR x1 units in 20‐‐ which is expected to
reach INR x2 units approximately by 20‐‐
• The Stem Cell Banking Market was worth INR y1 units in 20‐‐ and is expected to reach INR y2
Market units in 20‐‐
• India is projected to see a rise in number of stem cell bank and stem cell depositors in near
India is projected to see a rise in number of stem cell bank and stem cell depositors in near
future
Drivers: Challenges:
•Favorable Regulatory Environment
• High Cost of Therapy
High Cost of Therapy
•High Patient Population
• Capital intensive nature of research is
Drivers & •Application in Drug Development
decelerating the market
Challenges •Increasing Awareness
• ‘Development Costs’ of Stem Cell
•Growing Medical Tourism
resulting in slow progress of the market
•Increasing Health Expenditure
•Increasing Health Expenditure
• Efforts to increase awareness in stem cell
•Increasing partnerships
Trends •Increasing investments
• Easy financing opportunities in stem cell
banking
Major Players
Stem Cell Banks Company A, Company B, Company C, Company D, Company E, Company F
Competition Organization A, Organization B, Organization C, Organization D,
Organization A Organization B Organization C Organization D
Stem Cell Research Organizations
Organization E, Organization F, Organization G, Organization H
STEM CELL RESEARCH MARKET IN INDIA 2012.PPT 2

3. •Introduction
•Market Overview
•Drivers & Challenges
•Value Chain
•Market Trends
M k tT d
•Potential Stem Cell Sources
•Competition
 Stem Cell Banks
 Research Organizations
Research Organizations
•Recent Developments
•Strategic Recommendations
g
•Appendix
STEM CELL RESEARCH MARKET IN INDIA 2012.PPT 3

4. Stem cell banking and therapeutic application are the two
key area of concern which are bridged by stem cell research
Stem Cell can be the solution to a myriad of diseases like Parkinson's disease, amyotrophic lateral sclerosis, spinal
cord injury, burns, heart disease, diabetes and arthritis and also for neurological problems like autism and cerebral
palsy and is also becoming an important tool for testing potential drug toxicity
Stem Cell Therapy Stem Cell Banking
• It is a concept of preserving the stem cells for specific
• It is an emerging therapy wherein a damaged tissue future therapeutic uses
that cannot heal itself is repaired by the use of stem cell • The extraction of cord blood stem cells take about 10–15
• Stem cells are the unspecialized blood cell that has the minutes and is applicable to both normal and caesarean
capacity to replicate and produce its own blood cells, deliveries
platelets, red and white blood cells • The cells can be cryo‐frozen and kept stored for decades in
• The “Cord Blood” is a rich source of stem cells and a
The Cord Blood is a rich source of stem cells and a liquid nitrogen
liquid nitrogen
critical input for such surgical treatments • Cord blood is more like a ‘biological future health
insurance’ for the newborn baby and its future offspring’s
and siblings
Public Banks Private Banks
•Use not restricted •For use of family only
•No remuneration collected •Facility paid for by family
•Usage subject to availability •Availability guaranteed
The benefits of stem cell is manifold as the cell’s usage is not just restricted to the child but siblings or family members
can use the cells if required, after a tissue matching is done
STEM CELL RESEARCH MARKET IN INDIA 2012.PPT 4

5. Stem cell therapy market is poised to grow at a very high
rate due to increasing therapeutic applications
Stem Cell Therapy Market – Overview Market Size and Growth
• The Stem Cell Therapy market in India was valued at INR units
INR x1 units in 20‐‐
80
• The market is expected to reach INR x6 units x6
X%
approximately by 20‐‐, growing at a CAGR of X% for 60 x5
x4
this time period x2
x3
40 x1
• The stem cell research is a key factor that propels the x0
therapeutic market 20
• Almost m stem cell transplants are carried out in 0
India annually that is growing gradually 20‐‐ 20‐‐ 20‐‐e 20‐‐e 20‐‐e 20‐‐e 20‐‐e
Stem Cell Banking Market – Overview
Stem Cell Banking Market Overview Market Size and Growth
Market Size and Growth
• The Stem Cell Banking Market was worth INR y1 INR units
units in 20‐‐ and is expected to reach INR y6 units in 10 y6
20‐‐
8
• The stem cell b k
h ll banking market is expected to exhibit a
k d hb Y% y5
CAGR of Y% between 20‐‐ and 20‐‐ 6 y4
• Stem cell banking that was unheard of a few years 4 y3
back but has become popular in the recent past as a y2
y1
2 y0
less traumatic alternative to treat neurological
diseases and as guarantee for the entire family 0
against several other diseases 20‐‐ 20‐‐ 20‐‐e 20‐‐e 20‐‐e 20‐‐e 20‐‐e
STEM CELL RESEARCH MARKET IN INDIA 2012.PPT 5

6. Drivers & Challenges – Summary
Drivers
i
Favorable Regulatory Environment
Challenges
High Patient Population
High Cost of Therapy
Application in Drug Development
Capital Intensive Market
Increasing Awareness High Development Cost
Growing Medical Tourism
Increasing R&D Expenditure
STEM CELL RESEARCH MARKET IN INDIA 2012.PPT 6

7. Trends – Summary
Easy financing opportunities in
Increasing Partnerships
stem cell banking
Key
Trends
Efforts to increase awareness
Increasing Investments
in stem cell
STEM CELL RESEARCH MARKET IN INDIA 2012.PPT 7

8. Private: Foreign Company – Company A (1/3)
Company Information Offices and Centres – India
Company A
Street A
Corporate Address
City B
City B
State C
City B
Tel No. +91 124 7239
Fax No.
Fax No +91 124 4734111
+91 124 4734111
Website www.CompanyAcom
Year of Incorporation 2005
Products and Services
P d t dS i Head Office
Category Products/Services
Engages in collection, isolation and Key People
Stem cell banking
storage of cord blood stem cells
Name Designation
Person A Chairman
Person B Managing Director
Person C
Person C CEO
STEM CELL RESEARCH MARKET IN INDIA 2012.PPT 8

9. Private: Foreign Company – Company A (2/3)
Financial Snapshot
i i lS h Key Ratios
K i
y‐o‐y change
Total Income Net Profit/Loss Particulars
(2011‐10)
2011 2010 2009 2008
INR units INR units Profitability Ratios
Operating Margin
250 ‐20
20
Net Margin
200 a Profit Before Tax Margin
‐40 Return on Equity
150 d
b c R4 Return on Capital Employed
100 R3 Return on Working Capital
‐60
50 R2 Return on Assets
R1 Return on Fixed Assets
0 ‐80 Cost Ratios
20‐‐ 20‐‐ 20‐‐ 20‐‐ Operating costs (% of Sales)
Administration costs (% of
Sales)
Financial Summary Interest costs (% of Sales)
Interest costs (% of Sales)
• The company incurred a net loss of INR d units in FY 20‐‐, as Liquidity Ratios
Current Ratio
compared to net loss of INR c units in FY 20‐‐
Cash Ratio
• The company reported total income of INR R4 units in FY 20‐‐, Leverage Ratios
registering an increase of m% over FY 20‐‐ Debt to Equity Ratio
Debt to Capital Ratio
b i l i
• The company earned an operating margin of f% in FY 20‐‐, an Interest Coverage Ratio
increase of g percentage points over FY 20‐‐ Efficiency Ratios
• The company reported debt to equity ratio of d in FY 20‐‐, a Fixed Asset Turnover
decrease of h% over FY 20‐‐ Asset Turnover
Current Asset Turnover
Working Capital Turnover
Capital Employed Turnover
Improved Decline
STEM CELL RESEARCH MARKET IN INDIA 2012.PPT 9

10. Private: Foreign Company – Company A (3/3)
Business Highlights
Description News
Overview • It was formed as a joint venture between Company A and Company B
Stem Cell Banking • It provides collection facility from all major cities in India
• The company was awarded the most prestigious American Association of Blood Banks
Recognitions (AABB) Accreditation
STEM CELL RESEARCH MARKET IN INDIA 2012.PPT 10

11. Appendix
Ratio Calculations Ratio Calculations
(Operating Current Assets / Current
Operating Margin Current Ratio
Income/Revenues)*100 Liabilities
Net Margin (Net Profit / Revenues) *100 {(Cash & Bank Balance +
Cash Ratio Marketable Securities) / Current
(Income Before Tax / Revenues Liabilities)}
Profit Before Tax Margin
*100
Total Liabilities / Shareholders
q y
Debt to Equity
(Net Income / Shareholders
(N I / Sh h ld Equity
E it
Return on Equity (ROE)
Equity)*100
{Total Debt / (Shareholders
Debt to Capital Ratio
EBIT / (Total Assets – Current Equity + Total Debt)}
Return on Capital (ROCE)
Liabilities)*100
Interest Coverage Ratio EBIT / Interest Expense
(Net Income / Working Capital)
(N I / W ki C i l)
Return on Working Capital
*100
Fixed Asset Turnover Sales / Fixed Assets
Return on Assets (Net Income / Total Assets)*100
Asset Turnover Sales / Total Assets
Return on Fixed Assets (Net Income / Fixed Assets) *100
(Operating Expenses / Sales) Current Asset Turnover Sales / Current Assets
Operating Costs (% of Sales)
*100
Administration Costs (% of (Administrative Expenses / Sales) Working Capital Turnover Sales / Working Capital
Sales) *100
Interest Costs (% of Sales) (Interest Expenses / Sales) *100 Capital Employed Turnover Sales / Shareholders Equity
/
STEM CELL RESEARCH MARKET IN INDIA 2012.PPT 11

12. Thank you for the attention
The Stem Cell Research Market – India report is part of Research on India’s Healthcare Series.
For more detailed information or customized research requirements please contact:
Phone: +91 33 4064 6214
91 33 4064 6214
E‐Mail: sales@netscribes.com
Follow us on:
About Netscribes
Netscribes is a knowledge‐consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment &
g g f g p y p p f
business research, business & corporate intelligence, content‐management services, and knowledge‐software services. At its core lies a true
value proposition that draws upon a vast knowledge base. Netscribes is a one‐stop shop designed to fulfil clients’ profitability and growth
objectives.
Disclaimer: This report is published for general information only. Although high standards have been used in the preparation, Netscribes is
Disclaimer: This report is published for general information only Although high standards have been used in the preparation “Netscribes” is
not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes and prior
permission is required for guidelines on reproduction.
STEM CELL RESEARCH MARKET IN INDIA 2012.PPT 12